Production isolator Cellana-M
asepticfor biopharmaceutical applicationsfor cellular therapy

Production isolator - Cellana-M - Skan - aseptic / for biopharmaceutical applications / for cellular therapy
Production isolator - Cellana-M - Skan - aseptic / for biopharmaceutical applications / for cellular therapy
Production isolator - Cellana-M - Skan - aseptic / for biopharmaceutical applications / for cellular therapy - image - 2
Production isolator - Cellana-M - Skan - aseptic / for biopharmaceutical applications / for cellular therapy - image - 3
Production isolator - Cellana-M - Skan - aseptic / for biopharmaceutical applications / for cellular therapy - image - 4
Production isolator - Cellana-M - Skan - aseptic / for biopharmaceutical applications / for cellular therapy - image - 5
Production isolator - Cellana-M - Skan - aseptic / for biopharmaceutical applications / for cellular therapy - image - 6
Add to favorites
Compare this product

Characteristics

Applications
for production, aseptic, for biopharmaceutical applications, for cellular therapy, for clinical research, for regenerative medicine, for cell culture
ISO class
ISO class 5
Type of products handled
for biological products
Configuration
modular
Other characteristics
stainless steel, glove box, negative pressure, with incubator, flexible, with HEPA filter, positive pressure
External width

217.5 cm
(85.63 in)

External depth

120 cm
(47.24 in)

External height

248.8 cm
(97.95 in)

Weight

2,200 kg
(4,850.17 lb)

Description

Overview
Flexible isolator solution designed for aseptic ATMP production, enabling closed workflows from thawing to filling within a Grade A environment.

Key features
  • Highest sterility assurance levels: complete separation between the Grade A process environment and the operator.
  • Fastest decontamination cycles: automated >6-log H₂O₂ decontamination enables extremely short cycle times for time-sensitive products.
  • Modular design: various chamber configurations and glove options allow optimal adaptation to specific processes.
  • Flexible equipment integration: seamless integration of centrifuges, CO₂ incubators, microscopes and other process equipment.
  • Multiple transfer options: H₂O₂ decontamination airlocks, Rapid Transfer Ports (RTP), alpha/beta RTP systems and AT-Port for sterile liquid transfers.
  • All processes on a single platform: full workflows from thawing to filling can be executed within the isolator without open transfers.
  • Integrated process controls: continuous, documented environmental monitoring and process control (digital records).
  • Reduced operating costs: lower gowning and energy requirements through isolator technology, enabling background cleanroom downgrade to Grade C/D.

Applications
  • Preclinical and clinical studies for cell, tissue and gene therapies such as CAR‑T, iPSCs, MSCs.
  • Upstream and downstream processes covering cell modification, expansion and final formulation.
  • Aseptic filling of ATMPs into vials, bags or other primary containers; compatible with integrated or connected filling systems.

Process workflow (summary)
  • 1. Cell thawing and transfer: sterile transfer of cryo vials via integrated airlock with validated fast H₂O₂ decontamination cycles; adapted programs for sensitive materials.
  • 2. Inoculum preparation and centrifugation: integrated centrifuge configurable up to 4 × 1000 mL, temperature range –20°C to +40°C; all steps performed inside the isolator to eliminate open transfers.
  • 3. Cell culture and expansion: integrated or removable CO₂ incubators with stainless-steel, H₂O₂-compatible interiors; continuous monitoring and recording of temperature and CO₂.
  • 4. Harvest and formulation: washing, formulation and transfer using integrated pumping and filling systems to maintain a closed process chain.
  • 5. Aseptic filling: controlled, reproducible dosing into final containers (vials, syringes, bags) without open handling steps.

Product highlights
  • Plug-and-play solution: modular, customizable design available as a standardized platform to reduce lead times and commissioning effort.
  • Protection of product and operators: closed Grade A environment with dual HEPA filtration, configurable positive/negative pressure and integrated H₂O₂ decontamination.
  • Improved operational efficiency: reduced monitoring effort, simplified gowning and better working conditions.

Regulatory requirements
  • Designed to meet stringent GMP standards for ATMP production; sterility assurance level (SAL) of 10⁻⁶.
  • Risk reduction through full separation of process and operator, minimizing human error and cross-contamination risks.
  • Digital compliance: integrated control systems supporting monitoring, operation and documentation in compliance with 21 CFR Part 11 (complete digital records).

Technical characteristics / specifications
  • Application type: Aseptic.
  • Customization level: Modular configuration.
  • Flexible chamber size (general): 1000 × 800–1250 × 750–1200 mm (W × H × D).
  • Size (four-glove chamber): 2175 × 2488 × 1200 mm (W × H × D).
  • Weight (four-glove chamber): 2200 kg.
  • Automated decontamination: validated >6-log H₂O₂ decontamination for chambers and airlocks.
  • Airlocks: various H₂O₂ decontamination airlock options.
  • Rapid Transfer Ports (RTP): H₂O₂ RTP and alpha/beta RTP systems available.
  • AT-Port: for sterile liquid transfers.
  • Centrifuge options: configurations from 1 L to 4 L; configurable up to 4 × 1000 mL with temperature range −20°C to +40°C.
  • Incubator: integrated or removable incubators available in different sizes; stainless-steel interior compatible with H₂O₂.
  • Additional process integrations: peristaltic pumps, microscopes and other equipment can be integrated.

Catalogs

No catalogs are available for this product.

See all of Skan‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.